Last edition
News about "Biocytogen Pharmaceuticals "
Biocytogen Signs Non-Exclusive VHH Antibody Licensing Deal with Qilu Pharmaceutical
Biocytogen grants Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule developed through its RenNano platform to support neuroscience drug research.
Biocytogen Pharmaceuticals | 04/09/2026 | By News Bureau | 113
Biocytogen and Sihuan Pharmaceutical Partner to Advance Next-Gen Antibody Therapies
The strategic collaboration between Bioctogen and Sihuan Pharmaceutical combines antibody discovery platforms and manufacturing expertise to accelerate development of innovative treatments, including weight loss therapies.
Biocytogen Pharmaceuticals | 06/04/2026 | By News Bureau | 143
Biocytogen Grants Licence for RenNano Platform to Taisho Pharmaceutical
Biocytogen licenses its RenNano platform to Taisho Pharmaceutical to advance fully human heavy chain-only antibody discovery, supporting in-vivo screening and downstream research.
Biocytogen Pharmaceuticals | 31/03/2026 | By News Bureau | 190
The strategic collaboration between Biocytogen Pharmaceuticals Beijing and Moonlight Bio aims to combine antibody discovery and cell therapy expertise to develop innovative treatments for hard-to-treat cancers.
Biocytogen Pharmaceuticals | 25/03/2026 | By News Bureau | 209
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy